Neurocrine Biosciences, Inc.
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Dec 2023 | 53.34x | $2.47 | $131.76 |
| Dec 2024 | 41.49x | $3.29 | $136.50 |
| Dec 2025 | 30.18x | $4.67 | $140.95 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Dec 2023 | 53.34x | $2.47 | $131.76 |
| Dec 2024 | 41.49x | $3.29 | $136.50 |
| Dec 2025 | 30.18x | $4.67 | $140.95 |